SOTERIA Precision Medicine Advisory, Inc. and CureMatch, Inc. have entered into an agreement that will facilitate the delivery of Personalized Combination Therapy® options to the global cancer care community. As a premier concierge precision medicine advisory company, Soteria provides client guidance related to individualized tumor profiling services. In turn, CureMatch evaluates a patient’s sequencing data and prior drug history to rank the top mono-therapies, two-drug combinations, and three-drug combinations along with any specifically selected treatment options for the oncologists’ consideration.
